Quest Diagnostics Other Long-Term Assets 2010-2024 | DGX

Quest Diagnostics other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Quest Diagnostics other long-term assets for the quarter ending September 30, 2024 were $0.272B, a 82.55% increase year-over-year.
  • Quest Diagnostics other long-term assets for 2023 were $0.198B, a 37.5% increase from 2022.
  • Quest Diagnostics other long-term assets for 2022 were $0.144B, a 11.66% decline from 2021.
  • Quest Diagnostics other long-term assets for 2021 were $0.163B, a 7.39% decline from 2020.
Quest Diagnostics Annual Other Long-Term Assets
(Millions of US $)
2023 $198
2022 $144
2021 $163
2020 $176
2019 $160
2018 $119
2017 $136
2016 $148
2015 $174
2014 $172
2013 $215
2012 $559
2011 $281
2010 $189
2009 $151
Quest Diagnostics Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $272
2024-06-30 $216
2024-03-31 $182
2023-12-31 $198
2023-09-30 $149
2023-06-30 $152
2023-03-31 $150
2022-12-31 $144
2022-09-30 $132
2022-06-30 $137
2022-03-31 $155
2021-12-31 $163
2021-09-30 $155
2021-06-30 $176
2021-03-31 $170
2020-12-31 $176
2020-09-30 $164
2020-06-30 $158
2020-03-31 $188
2019-12-31 $160
2019-09-30 $152
2019-06-30 $141
2019-03-31 $126
2018-12-31 $119
2018-09-30 $118
2018-06-30 $128
2018-03-31 $128
2017-12-31 $136
2017-09-30 $146
2017-06-30 $146
2017-03-31 $147
2016-12-31 $148
2016-09-30 $155
2016-06-30 $223
2016-03-31 $204
2015-12-31 $174
2015-09-30 $163
2015-06-30 $275
2015-03-31 $309
2014-12-31 $172
2014-09-30 $229
2014-06-30 $227
2014-03-31 $213
2013-12-31 $215
2013-09-30 $220
2013-06-30 $219
2013-03-31 $566
2012-12-31 $559
2012-09-30 $224
2012-06-30 $288
2012-03-31 $275
2011-12-31 $281
2011-09-30 $273
2011-06-30 $234
2011-03-31 $189
2010-12-31 $189
2010-09-30 $188
2010-06-30 $183
2010-03-31 $159
2009-12-31 $151
2009-09-30 $143
2009-06-30 $142
2009-03-31 $144
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.877B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00